Siddhartha S Mitra

15PUBLICATIONS
61CO-AUTHORS
Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 05, 2025
Differential phagocytosis induces diverse macrophage activation states in malignant gliomas.

Senthilnath Lakshmanachetty, Kent Riemondy, Bridget Sanford

|May 27, 2025
Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma.

Ilango Balakrishnan, Krishna Madhavan, Angela Pierce

|Apr 01, 2025
Differential Phagocytosis induces Diverse Macrophage Activation States in Malignant Gliomas.

Senthilnath Lakshmanachetty, Kent Riemondy, Bridget Sanford

|Jul 10, 2024
Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous Carcinoma.

Ritsuko Iwanaga, Tomomi M Yamamoto, Karina Gomez

|Jan 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.

Viktoria Marquardt, Johanna Theruvath, David Pauck

|Mar 28, 2022
Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth.

Krishna Madhavan, Ilango Balakrishnan, Senthilnath Lakshmanachetty

Pageof 3

Frequent Collaborators

4 joint publications

Senthilnath Lakshmanachetty

3 joint publications

Xin Wang

3 joint publications

Sujatha Venkatraman

3 joint publications

Gregor Hutter